tirzepatide for perimenopause Oova | Hormone Tracking | A new Mayo Clinic led study found that postmenopausal women taking (an FDA-approved weight-loss medication) lost ~35% more Perimenopause And GLP-1 Weight Loss

Zhao et al

Dysfunction of these organelles can lead to various diseases, including diabetes, neurodegenerative diseases, CVDs, and cancer, making them potential therapeutic targets

R et al., 2022

Sci Rep 15 , 15120 (2025)

People who combine the medication with consistent exercise and whole-food nutrition typically see better results than those relying on semaglutide alone

Please see Medication Guide and Prescribing Information, including Boxed Warning, for Wegovy at About Novo Nordisk Novo Nordisk is a leading global healthcare company that's been making innovative medicines to help people with diabetes lead longer, healthier lives for more than 100 years